OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
OnKure Therapeutics (NASDAQ:OKUR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: VANGUARD GROUP INC
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Mathers Edward T
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.